Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Incidence of acute rejection by type of interleukin-2 receptor
antibody. Note that only overall follow up data (six to 26 months) were
available for anti-Tac and 12 week data for BT563